Comment on Drozdowska-Szymczak et al. Incidence and Risk Factors of Cholestasis in Newborns with Hemolytic Disease—A Case-Control Study. J. Clin. Med. 2024, 13, 3190
Jonas Teng, Björn Fischler, Kajsa Bohlin, Marie Reilly, Eleonor Tiblad, Erich Cosmi · 2024
Read Comment on Drozdowska-Szymczak et al. Incidence and Risk Factors of Cholestasis in Newborns with Hemolytic Disease—A Case-Control Study. J. Clin. Med. 2024, 13, 3190 by Jonas Teng, Björn Fischler, Kajsa Bohlin, Marie Reilly, Eleonor Tiblad, Erich Cosmi (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11642077.txt.
Description
A peer-reviewed research article from Europe PMC (2024). tudy” [1], because the topic is of clinical importance and further research is warranted. However, we have several objections regarding the methodology and interpretation of the results that we would like to share with you. In this retrospective observational study, the researchers investigate the risk factors and incidence rate of cholestasis among newborn infants with hemolytic disease of the fetus and newborn (HDFN) during a four-year period in a single center.
Catalog record
| CREATOR | Jonas Teng, Björn Fischler, Kajsa Bohlin, Marie Reilly, Eleonor Tiblad, Erich Cosmi |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 5 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |